Trials / Completed
CompletedNCT06660251
Effect of Meat and Egg on TMAO in Plasma and Urine in Subjects with and Metabolic Subjects
Trimethylamine-N-oxide After Animal Food - Effects of Gut Microbiota in Subjects with and Without Metabolic Syndrome
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- Linnaeus University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this clinical trial is to investigate in subjects with and without metabolic syndrome how meals of choline- and carnitine-rich foods (eggs and meat) affect the trimethylamine-N-oxide (TMAO) concentration in blood and urine in relation to the gut microbiota composition. In response to the subjects´ gut microbiota, the concentrations of TMAO in the plasma and urine of subjects with and without metabolic syndrome (MetS) after ingesting choline- and carnitine-rich foods will be compared. On two occasions, participants will receive after overnight fasting meatballs (170 g) or three hard-boiled eggs. Blood will be collected before ingestion and over 6 hours after test food consumption.
Detailed description
There is a growing interest in the role of the intestinal microbiota in the global metabolism of their host. Trimethylamine-N-oxide (TMAO), a metabolite linked to the gut microbiota, has recently emerged as a risk metabolite for cardiovascular disease. The gut microbiota composition was reported to be altered in MetS. After ingestion of foods high in trimethylamine moieties, postprandial TMAO in blood may differ between subjects with and without MetS because of their different microbiota profiles. Aim of the study is to investigate in subjects with and without MetS the postprandial TMAO concentrations in blood and urine in association with the gut microbiota profile after ingestion of choline- and L-carnitine-rich foods. Thirty-three subjects aged 18-75 years with (n=12) or without MetS (n=21) were recruited. Subjects received on two occasions, after overnight fasting, either three hard-boiled eggs or 170 g meatballs. Blood samples were collected (before ingestion of food, and at 30, 60, 120, 240, and 360 minutes after ingestion). A composite urine sample was collected over 6 hours. A feces sample was collected on the day before the first intervention. Concentrations of TMAO, trimethylamine, betaine, choline, L-carnitine, acetyl-L-carnitine, and creatinine were measured UPLC-MRM-MS. The incremental area under the curve (iAUC) was calculated for each compound. TMAO, trimethylamine, betaine, choline, L-carnitine, acetyl-L-carnitine, and creatinine were analyzed in composite urine samples using UPLC-MRM-MS. Gut microbiome analysis was done by full 16S rRNA gene sequencing using the Oxford Nanopore Technology.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Egg intervention | Oral administration of three hard-boiled eggs to be ingested within 15 minutes on one occasion. |
| OTHER | Meatball intervention | Oral intervention with 170 g meatballs to be ingested within 15 minutes on one occasion. |
Timeline
- Start date
- 2020-02-07
- Primary completion
- 2023-05-05
- Completion
- 2024-05-05
- First posted
- 2024-10-28
- Last updated
- 2024-10-28
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT06660251. Inclusion in this directory is not an endorsement.